Vertex Pharmaceuticals Stock Soars as Non-Opiod Pain Treatment Gets FDA Nod

Vertex Pharmaceuticals' newly FDA-approved non-opioid analgesic, Journavx, offers a groundbreaking alternative for managing acute pain. The post Vertex Pharmaceuticals Stock Soars as Non-Opiod Pain Treatment Gets FDA Nod appeared first on Tokenist. source: https://tokenist.com/vertex-pharmaceuticals-stock-soars-as-non-opiod-pain-treatment-gets-fda-nod/?utm_source=rss&utm_medium=rss&utm_campaign=vertex-pharmaceuticals-stock-soars-as-non-opiod-pain-treatment-gets-fda-nod